Kirmani Bilal H, Akowuah Enoch
Department of Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool L14 3PE, UK.
Cardiac Surgery, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
J Cardiovasc Dev Dis. 2023 Jun 30;10(7):281. doi: 10.3390/jcdd10070281.
Minimally invasive approaches to the aortic valve have been described since 1993, with great hopes that they would become universal and facilitate day-case cardiac surgery. The literature has shown that these procedures can be undertaken with equivalent mortality rates, similar operative times, comparable costs, and some benefits regarding hospital length of stay. The competing efforts of transcatheter aortic valve implantation for these same outcomes have provided an excellent range of treatment options for patients from cardiology teams. We describe the current state of the art, including technical considerations, caveats, and complications of minimal access aortic surgery and predict future directions in this space.
自1993年以来，人们就一直在描述主动脉瓣的微创治疗方法，寄望它们能够普及并推动日间心脏手术的开展。文献表明，这些手术能够在死亡率相当、手术时间相近、成本相当的情况下进行，并且在缩短住院时间方面具有一定优势。经导管主动脉瓣植入术为实现相同治疗效果所做的努力，为心脏病学团队的患者提供了一系列出色的治疗选择。我们描述了目前的技术水平，包括微创主动脉手术的技术考量、注意事项和并发症，并预测了该领域未来的发展方向。
